The United States Food and Drug Administration (USFDA) has successfully concluded inspection at Torrent Pharmaceuticals’ Oral-Oncology manufacturing facility situated in Bileshwarpura, Gujarat. In this regard, USFDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility. The Inspection was conducted from December 05, 2023 to December 11, 2023.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
